Clincosm LogoSign in Get a demo

primary biliary cholangitis (pbc)

Showing 1 - 6 of 6
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Primary Biliary Cholangitis (PBC) Trial (Elafibranor, Matched 80 mg )

Not yet recruiting
  • Primary Biliary Cholangitis (PBC)
  • (no location specified)
Aug 29, 2023

Primary Biliary Cholangitis (PBC) Trial in Shanghai (2mg CS0159, Placebo)

Not yet recruiting
  • Primary Biliary Cholangitis (PBC)
  • 2mg CS0159
  • Placebo
  • Shanghai, Shanghai, China
    Renji Hospital, Shanghai Jiao Tong University School of Medicine
Jun 7, 2023

Primary Biliary Cholangitis (PBC), Liver Cirrhosis, Biliary Trial in Bunkyo-Ku, Fukuoka (OP-724)

Completed
  • Primary Biliary Cholangitis (PBC)
  • Liver Cirrhosis, Biliary
  • Bunkyō-Ku, Tokyo, Japan
  • +1 more
Jul 4, 2022

Chinese Primary Biliary Cholangitis on Ursodeoxycholic Acid

Recruiting
  • Primary Biliary Cholangitis (PBC)
  • Ursodeoxycholic Acid
  • Beijing, China
    Centre of non-infectious liver diseases, Beijing 302 Hospital, B
Aug 27, 2021

Primary Biliary Cholangitis (PBC) Trial in Guangzhou (Probiotic, Placebo)

Unknown status
  • Primary Biliary Cholangitis (PBC)
  • Guangzhou, Guangdong, China
    Third Affliated Hospital of Sun Yat-sen University
Jan 4, 2020

Primary Biliary Cholangitis (PBC) Trial in Worldwide (Elafibranor 80 mg, Elafibranor 120 mg, Placebo)

Completed
Has Results
  • Primary Biliary Cholangitis (PBC)
  • Elafibranor 80 mg
  • +2 more
  • Phoenix, Arizona
  • +23 more
Sep 20, 2019